HemaSphere
(Jun 2022)
P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION
- L. Bischof,
- J. Ussmann,
- D. Brauer,
- D. Backhaus,
- L. Herrmann,
- G.-N. Franke,
- V. Vucinic,
- K. H. Metzeler,
- U. Platzbecker,
- S. Schwind,
- M. Jentzsch
Affiliations
- L. Bischof
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- J. Ussmann
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- D. Brauer
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- D. Backhaus
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- L. Herrmann
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- G.-N. Franke
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- V. Vucinic
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- K. H. Metzeler
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- U. Platzbecker
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- S. Schwind
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- M. Jentzsch
- 1 Hematology, Leipzig University Hospital, Leipzig, Germany
- DOI
-
https://doi.org/10.1097/01.HS9.0000844924.32286.18
- Journal volume & issue
-
Vol. 6
pp.
408
– 409
WeChat QR code